Inactive Instrument

OmniComm Systems, Inc.

Omnicomm Systems, Inc. Announces Earnings Results for the Year Ended December 31, 2018

March 28, 2019 at 05:04 pm EDT

OmniComm Systems, Inc. announced earnings results for the year ended December 31, 2018. Total revenues SGD 27,104,480 compared to SGD 26,979,658 a year ago. Operating income was SGD 2,534,177 compared to SGD 3,534,150 a year ago. Net income was SGD 3,687,965 compared to SGD 2,967,218 a year ago. Net income per share was SGD 0.02 compared to SGD 0.02 a year ago.

Latest news about OmniComm Systems, Inc.

Gloria Janata acquired TogoRun from OmniComm Systems, Inc.	21-09-29	CI
Sofpromed CRO Adopts OmniComm’s TrialMaster® as EDC Solution for Clinical Trials in Oncology	19-12-16	CI
FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems for Multiple eClinical Products	19-12-02	CI
OmniComm Systems, Inc. Releases IRTMaster Version 5.2	19-11-25	CI
OmniComm Launches Next-generation Adaptable Fuel-level Sensors With 99.5% Guaranteed Accuracy	19-10-16	CI
Anju Software, Inc., Thisbe Merger Sub, Inc. and OmniComm Systems, Inc. Announces Management Changes	19-09-18	CI
Anju Software, Inc. completed the acquisition of OmniComm Systems, Inc..	19-09-17	CI
Omnicomm Systems, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
Global Biopharmaceutical Company Signs Five-Year Agreement to Use Technology Suite From OmniComm Systems for Rare Disease Studies	19-07-31	CI
Anju Software, Inc. entered into a merger agreement to acquire OmniComm Systems, Inc. for $65.7 million.	19-07-15	CI
Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster EDC	19-07-09	CI
Omnicomm Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-15	CI
Strong Growth Globally in Academic Medical Center Contracts for OmniComm Systems	19-05-01	CI
Rundo International Pharmaceutical Research & Development Co., Ltd. Selects eClinical Solutions from OmniComm Systems, Inc	19-04-11	CI
OmniComm Systems, Inc. Launches TrialOne® Express for Early Stage Research	19-04-02	CI
Omnicomm Systems, Inc. Announces Earnings Results for the Year Ended December 31, 2018	19-03-28	CI
CRO Signs Agreement With OmniComm Systems for TrialMaster® EDC	19-03-15	CI
European Medical Device Company Signs Multiyear Agreement to Use OmniComm's TrialMaster EDC for Ophthalmological Research	19-03-07	CI
KKS Düsseldorf Signs Multiyear Deal for OmniComm Systems, Inc.'s TrialMaster® EDC Technology	19-02-28	CI
Top 5 Global CRO Places Contract for OmniComm Systems, Inc.'s Newly Released Leading-Edge AutoEncoder	19-01-30	CI
Hitachi Inspharma Partners with Omnicomm to Offer eClinical Solutions in Japan	18-12-26	CI
Surrey Clinical Research Centre Signs Five-Year Contract Renewal with OmniComm Systems	18-12-13	CI
International Biopharmaceutical Company Selects OmniComm Systems, Inc.’s TrialMaster EDC for Multi-Study Cancer Research	18-11-27	CI
OmniComm Systems, Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018	18-11-13	CI
Global CRO Signs Seven-Year Trialone Agreement with OmniComm Systems, Inc	18-10-17	CI

Chart OmniComm Systems, Inc.

Duration

Period

More charts

Company Profile

OmniComm Systems, Inc. is engaged in providing Web-based electronic data capture (EDC) and eClinical (eClinical) software and services that manage the clinical research process. The Company's EDC and eClinical software and service offerings (eClinical Products or eClinical Solutions) consist of TrialMaster, TrialOne, Promasys, and eClinical Suite. Its eClinical Products allows clinical trial sponsors and investigative sites to collect, validate, transmit and analyze clinical study data. Its eClinical Products are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms. It also provides business process consulting services that focus on integrating EDC, and an array of eClinical Solutions and processes into the clinical trial process. The Company operates through the delivery of EDC Software and services to clinical trial sponsors segment. Its services include hosting solutions, consulting services, customer support and training.

Sector

IT Services & Consulting

More about the company

Sector Other IT Services & Consulting

	1st Jan change	Capi.
ACCENTURE PLC	-12.88%	191B
TATA CONSULTANCY SERVICES LTD.	+1.53%	167B
IBM	+3.89%	155B
AUTOMATIC DATA PROCESSING, INC.	+8.07%	103B
CROWDSTRIKE HOLDINGS, INC.	+36.59%	83.67B
RELX PLC	+11.45%	82.06B
INFOSYS LIMITED	-6.43%	71.76B
SNOWFLAKE INC.	-17.20%	54.05B
HCL TECHNOLOGIES LIMITED	-8.68%	43.53B

Other IT Services & Consulting